Tylosin tar­trate CAS 1405-54-5

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions andamp ; Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

1405-54-5

Name

Tylosin tar­trate

Syn­onyms

(2R,3R)-2,3-Dihydroxybernsteinsäure –[(2R,3R,6Z,9R,11R,12S,13S,14R)-12-{[3,6-didesoxy-4-O-(2,6-didesoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-3-(dimethylamino)-β-D-glucopyranosyl]oxy}-2-ethyl-14- hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl-6-desoxy-2,3-di-O-methyl-β-D-allopyranosid (1:1) [Ger­man] [ACD/IUPAC Name] (2R,3R)-2,3-Dihydroxysuccinic acid – [(2R,3R,6Z,9R,11R,12S,13S,14R)-12-{[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-3-(dimethylamino)-β-D-glucopyranosyl]oxy}-2-ethyl-14-hyd roxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-β-D-allopyranoside (1:1) [ACD/IUPAC Name] Acide (2R,3R)-2,3-dihydroxysuccinique – 6-désoxy-2,3-di-O-méthyl-β-D-allopyranoside de [(2R,3R,6Z,9R,11R,12S,13S,14R)-12-{[3,6-didésoxy-4-O-(2,6-didésoxy-3-C-méthyl-α-L-ribo-hexopyranosyl)-3-(d iméthylamino)-β-D-glucopyranosyl]oxy}-2-éthyl-14-hydroxy-5,9,13-triméthyl-8,16-dioxo-11-(2-oxoéthyl)oxacyclohexadéca-4,6-dién-3-yl]méthyle (1:1) [French] [ACD/IUPAC Name] Butane­dioic acid, 2,3-dihydroxy-, (2R,3R)-, com­pd. with (4R,5S,6S,7R,9R,11Z,15R,16R)-15-[[(6-deoxy-2,3-di-O-methyl-β-D-allopyranosyl)oxy]methyl]-6-[[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-α-L- ribo-hexopyranosyl)-3-(dimethylamino)-β-D-glucopyranosyl]oxy]-16-ethyl-4-hydroxy-5,9,13-trimethyl-2,10-dioxooxacyclohexadeca-11,13-diene-7-acetaldehyde (1:1) [ACD/​Index Name] (2R,3R)-2,3-dihydroxybutanedioic acid 1405-54-5 [RN] 2-[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde 74610-55-2 [RN] Tylosin (tar­trate) Tylosin tar­tar­ic acid Tylosin tar­trate

Mol­e­c­u­lar Structure

SMILES

CC[C@@H]1[C@H](/C=C(/C=C\C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O

Std­InChI

InChI=1S/C46H77NO17.C4H6O6/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35;5-1(3(7)8)2(6)4(9)10/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3;1-2,5-6H,(H,7,8)(H,9,10)/b15-14-,23-18-;/t24-,25+,26-,27-,28+,29+,30-,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-;1-,2-/m11/s1

Std­InChIKey

ICVKYY­IN­QH­WDLM-YOMZPPE­JSA-N

Mol­e­c­u­lar Formula

C46H77NO17.C4H6O6

Mol­e­c­u­lar Weight

1066.19

Prop­er­ties

Appear­ance

Off-white or light yel­low hygro­scop­ic pow­der

Safe­ty Data

WGK Germany

3 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Tylosin tar­trate CAS 1405-54-5

Stan­dard

EP

Iden­ti­fi­ca­tion Methods

HPLC

Tylosin com­po­si­tions

Tylosin A≥80% A+B+C+D≥95%

pH

5.0-7.2

Sul­phat­ed ash

≤2.5%

Tyra­mine

≤3.5%

Loss on Drying

≤4.5%

Poten­cy

≥800u/​mg

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

This prod­uct has spe­cial effects on mycoplas­ma, com­mon­ly used as anti-mycoplas­­ma drug of choice.

Gen­er­al View of Documents

Links

This prod­uct is devel­oped by our RD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​t​y​l​o​s​i​n​-​t​a​r​t​r​a​t​e​-​c​a​s​-​1​4​0​5​-​5​4​-5/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).